Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $26.2100 (-0.19%) ($25.8500 - $26.6100) on Thu. Jan. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.27% (three month average) | RSI | 77 | Latest Price | $26.2100(-0.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT advances 8.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.635% in a week (0% probabilities). VXX(-13%) VIXM(-9%) GDXJ(-6%) XHB(-4%) TLT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.635% (StdDev 5.27%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $26.01(0.77%) | 10 Day Moving Average | $25.69(2.02%) | 20 Day Moving Average | $23.71(10.54%) | To recent high | -17.6% | To recent low | 44.1% | Market Cap | $1.628b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |